<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/94FB5AD0-A6E5-4A49-8022-359A689D4259"><gtr:id>94FB5AD0-A6E5-4A49-8022-359A689D4259</gtr:id><gtr:name>Washington University in St Louis</gtr:name><gtr:address><gtr:line1>Washington University in St Louis</gtr:line1><gtr:line2>One Brookings Drive</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6016070E-2295-42D5-A27B-1CBC7B343688"><gtr:id>6016070E-2295-42D5-A27B-1CBC7B343688</gtr:id><gtr:name>Baylor Scott &amp; White Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/94FB5AD0-A6E5-4A49-8022-359A689D4259"><gtr:id>94FB5AD0-A6E5-4A49-8022-359A689D4259</gtr:id><gtr:name>Washington University in St Louis</gtr:name><gtr:address><gtr:line1>Washington University in St Louis</gtr:line1><gtr:line2>One Brookings Drive</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6016070E-2295-42D5-A27B-1CBC7B343688"><gtr:id>6016070E-2295-42D5-A27B-1CBC7B343688</gtr:id><gtr:name>Baylor Scott &amp; White Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/09F99D10-A92D-4E20-B568-8C616A0FF4E7"><gtr:id>09F99D10-A92D-4E20-B568-8C616A0FF4E7</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>O'Garra</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117565642"><gtr:id>B7E1854F-85CA-4A03-BC95-AACF025F2D33</gtr:id><gtr:title>Regulation Of The Innate And Adaptive Immune Response Against Pathogens And Their Products</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117565642</gtr:grantReference><gtr:abstractText>White blood cells or leucocytes originating in the bone marrow when functionally mature are found in blood and lymphoid tissue and respond to infectious organisms by producing various effector molecules important for the eradication of the pathogen. Amongst these cells, dendritic cells are key initiators of such immune responses and play a key role in activating leucocytes, known as CD4+ T helper cells and CD8+ T killer cells, which produce substances key to protect the host from pathogens such as viruses, bacteria and parasites. In addition, the CD4+ T helper cells produce patterns of molecules called cytokines which play an important role in regulating other white blood cells involved in eradication of infectious organisms, but these need to be regulated so as to inflict minimum damage to the host. This is important since these cytokines can also activate cells which give rise to pathology, such as autoimmunity or allergy. Our research involves the study at a molecular level of how dendritic cells and T helper cells can be activated to elicit the right kind of immune response, and how this immune response is regulated in infection (e.g. tuberculosis and influenza) to eradicate infectious organisms with minimum damage to the individual.</gtr:abstractText><gtr:technicalSummary>The type of immune response and effector cytokines elicited to pathogens can determine the outcome of infection. A major lab research focus is the regulation and function of cytokines in immune responses, defining molecular mechanisms of induction of the immunosuppressive cytokine IL-10 versus that of proinflammatory cytokines in immune cells. Although a major function of IL-10 is to regulate inflammation and damage to the host, a penalty is that IL-10 can also contribute to chronic infection. Recently my lab research has been expanded to study of the immune response in tuberculosis (TB), still a major global cause of morbidity and mortality. We have shown that IL-10 can contribute to chronic infection with Mycobacterium tuberculosis (MTb) by diminishing protective T helper (Th)1 responses and the production of IFN-? in the lung. The immune response to MTb is complex and incompletely characterized, hindering development of new diagnostics, treatments and vaccines. Although T cells and the cytokines TNF, IFN-?? and IL-12, are important for immune control of MTb infection, there is an incomplete understanding of the host factors determining protection or pathogenesis in TB. Using an unbiased whole genome array analysis of the transcriptome in blood of TB patients, we have identified potential factors leading to TB pathogenesis. Modular, pathway and gene analyses revealed a striking interferon (IFN)-inducible neutrophil-driven signature of active TB correlating with extent of radiographic disease, which was represented by Type I IFN as well as IFN-?? -inducible genes. This forms the basis of a patent, and the work is now accepted for publication in the journal Nature. We are now in an excellent position to apply the knowledge obtained from our study of human TB to further develop mouse models of TB and define mechanisms and potential determinants of pathogenesis. We will build on our past results to investigate further the molecular mechanisms for induction of IL-10 production and function. IL-10 is produced by multiple cells of the innate and adaptive immune response and thus is not controlled by a strict trajectory of cellular differentiation and is under the control of both cell intrinsic and extrinsic positive and negative regulatory loops in macrophages. Such control mechanisms, although likely, have not as yet been shown in other immune cells. Thus we will continue to characterize mechanisms of induction and regulation of IL-10 in macrophages, dendritic cells and T cells to uncover common and/or distinct mechanisms for its production. We will use basic molecular tools to delineate mechanisms of IL-10 expression both in vitro and in vivo and also extend this to in vivo models of infection with intracellular pathogens, with emphasis on TB. Leading on from our findings in human TB, we will dissect further potential factors in TB pathogenesis, using improved mouse models of TB. We will also use our findings to improve and define transcriptional biomarkers to enhance TB diagnosis and distinguish it from other lung diseases, and define prognostic markers predictive of outcome of latent TB to help develop targeted therapies needed to reduce the burden of TB globally. Technologies used include cell culture, flow cytometry immunoassay, in vivo whole animal immune responses, biochemical and molecular analysis of intracellular signalling pathways and gene regulation (protein and DNA-based technology), microarray technology of host mRNA.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>14320245</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor Scott &amp; White Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Baylor Institute for Immunology Research</gtr:department><gtr:description>Transcriptional Profiling in Latent and Active tuberculosis</gtr:description><gtr:id>2C98DB14-DBAE-47BE-B64C-4E7B96E4BD5E</gtr:id><gtr:impact>2 patents has been successfully filed and published and a third submitted, on these findings as a potential diagnostic, and now updated for describing factors potentially involved in pathogenesis of active TB disease. A manuscript has now been submitted to the journal Nature with these findings and an abstract has now been published in Thorax, Berry et al. and in the journal Nature, and more recently McNab et al., 2011, EJI; and Bloom et al., 2012.</gtr:impact><gtr:outcomeId>4B295CE7AC6-1</gtr:outcomeId><gtr:partnerContribution>We have recruited and studies patients with active tuberculosis disease in London and South Africa. With technology provided by the Baylor Institute for Immunology Research for microarray analysis of transcriptional profiles in blood of tuberculosis patients we have described a signature which distinguishes latent asymptomatic tuberculosis patients from those with active disease and have also found a potentially predictive signature of active tuberculosis patients in 10% of latent individuals. A patent has been successfully filed on these findings as a potential diagnostic, and now updated for describing factors potentially involved in pathogenesis of active TB disease. A manuscript has now been submitted to the journal Nature with these findings and an abstract has now been published in Thorax, Berry et al. This study was published in the journal Nature in August 2010, and more recently McNab et al., 2011, EJI; and Bloom et al., 2012</gtr:partnerContribution><gtr:piContribution>We recruited the patients, performed the microarray data analysis and the immunological experiemtns on patient material, wrote the paper and the patent with the Balyor lawyers. Baylor Institute for Immunology Research contributed the microarray technology and the training for analysis of complex micorarray data by the MRC NIMR team.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Washington University in St Louis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathology &amp; Immunology</gtr:department><gtr:description>IL-10 production in T helper cells</gtr:description><gtr:id>24EC4EA5-A382-47C4-8935-337AFF037661</gtr:id><gtr:impact>his led to a publication in the journal Immunity PMID: 19646904.</gtr:impact><gtr:outcomeId>B873414BB2C-1</gtr:outcomeId><gtr:partnerContribution>By providing mice provided by our collaborators at Washington Unversity, with particular genetic mutations we were able to show that all differentiated T helper cells produce the suppressive cytokine Interleukin-10 leading to feedback regulation of immune responses to stop host damage. We also further identified molecular pathways for IL-10 gene regulation. This led to a publication in the journal Immunity PMID: 19646904.</gtr:partnerContribution><gtr:piContribution>By providing mice provided by our collaborators at Washington Unversity, with particular genetic mutations we were able to show that all differentiated T helper cells produce the suppressive cytokine Interleukin-10 leading to feedback regulation of immune responses to stop host damage. We also further identified molecular pathways for IL-10 gene regulation. This led to a publication in the journal Immunity PMID: 19646904.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>Induction of IL-10 in T cells from steroid-resistant patients using Vitamin D3</gtr:description><gtr:id>F5A9770D-5A47-497E-B8D8-BF3E99B1EFA7</gtr:id><gtr:impact>We defined the ability of vitamin D3 and dexamethasone to induce IL-10 production in mouse and human (with our collaborator C. Hawrylowicz) CD4+ T cells, and are using these findings to enhance our knowledge of the mechanisms whereby IL-10 is induced in T cells. Professor Hawrylowicz has advanced this work by showing that vitamin D3 can overcome the inability of T cells from steroid-resistant asthma patients to respond to TCR signalling to produce IL-10. This furthers the mechanism of action of this drug and raises it's potential use in asthma treatment. This led to a collaobrative publication in 2006 in the Journal of Investigation Xystrakis et al., PMID: 16341266</gtr:impact><gtr:outcomeId>0678A29151B-1</gtr:outcomeId><gtr:partnerContribution>We defined the ability of vitamin D3 and dexamethasone to induce IL-10 production in mouse and human (with our collaborator C. Hawrylowicz) CD4+ T cells, and are using these findings to enhance our knowledge of the mechanisms whereby IL-10 is induced in T cells. Professor Hawrylowicz has advanced this work by showing that vitamin D3 can overcome the inability of T cells from steroid-resistant asthma patients to respond to TCR signalling to produce IL-10. This furthers the mechanism of action of this drug and raises it's potential use in asthma treatment.</gtr:partnerContribution><gtr:piContribution>We defined the ability of vitamin D3 and dexamethasone to induce IL-10 production in mouse and human (with our collaborator C. Hawrylowicz) CD4+ T cells, and are using these findings to enahnce our knowledge of the mechanisms whereby IL-10 is induced in T cells. Professo Hawrylowicz has advanced this work by showing that vitamin D3 can overcome the inability of T cells from steroid-resistant asthma patients to respond to TCR signalling to produce IL-10. This furthers the mechanism of action of this drug and raises it's potential use in asthma treatment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Transcriptional signatures of active versus latent tuberculosis</gtr:description><gtr:id>E227B6D3-F8C1-448E-A564-80A4F8E52A4C</gtr:id><gtr:impact>2 patents has been successfully filed and published and a third submitted, on these findings as a potential diagnostic, and now updated for describing factors potentially involved in pathogenesis of active TB disease. A manuscript has now been submitted to the journal Nature with these findings and an abstract has now been published in Thorax, Berry et al. and in the journal Nature, and more recently McNab et al., 2011, EJI; and Bloom et al., 2012.</gtr:impact><gtr:outcomeId>FJWASoAwiz7-1</gtr:outcomeId><gtr:partnerContribution>We have recruited and studies patients with active tuberculosis disease in London and South Africa in part with the help of Imperial College collaborators. With technology provided by the Baylor Institute for Immunology Research for microarray analysis of transcriptional profiles in blood of tuberculosis patients we have described a signature which distinguishes latent asymptomatic tuberculosis patients from those with active disease and have also found a potentially predictive signature of active tuberculosis patients in 10% of latent individuals. A patent has been successfully filed on these findings as a potential diagnostic, and now updated for describing factors potentially involved in pathogenesis of active TB disease. A manuscript has now been submitted to the journal Nature with these findings and an abstract has now been published in Thorax, Berry et al. This study was published in the journal Nature in August 2010, and more recently McNab et al., 2011, EJI; and Bloom et al., 2012</gtr:partnerContribution><gtr:piContribution>We recruited the patients, with the help of London and South Africa Hospitals in part with the help of Imperial College collaborators, performed the microarray data analysis and the immunological experiments on patient material, wrote the paper and the patent with the Balyor lawyers. Baylor Institute for Immunology Research contributed the microarray technology and the training for analysis of complex micorarray data by the MRC NIMR team.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Scientific Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0CA8753B-82AC-4D84-A5E2-EE8DD7D6AA9A</gtr:id><gtr:impact>300 delegates attended
Keystone Conference on Innate Immunity
Brasil

Many applicants to my lab</gtr:impact><gtr:outcomeId>qmcRcd88zpn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>58540B2B-9183-408F-8D62-613E918D5A1C</gtr:id><gtr:impact>Gave a talk on immunology and infection to biology class - A Level class - Henrietta Barnett School

Opened up knowledge gap for a number of pupils some of which were intending to follow medical/research career</gtr:impact><gtr:outcomeId>095F3414C2D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6623B264-D061-4FD1-99B5-85B5D4E20E93</gtr:id><gtr:impact>Talks sprked multiple questions and discussions during and afterwards

Talks led to multiple student placements at the NIMR in my laboratory and those of others</gtr:impact><gtr:outcomeId>54604b78425039.82201196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C4D00BAA-3A50-4A93-B717-88BA77ED3F73</gtr:id><gtr:impact>Cold Spring Harbor Symposium Conferecne, May-June 2013,
CSH, USA

Many applicants to my lab</gtr:impact><gtr:outcomeId>G8GiRnDWGK7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>162356</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dana Foundation-Research Grant-2007</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Dana Foundation</gtr:fundingOrg><gtr:id>BD12E72E-E02C-4F33-9ACF-8BBEC9D0EDD4</gtr:id><gtr:outcomeId>E9FC9B74D290</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250410</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Merieux-Research Grants</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Merieux Institute (Institut M?rieux)</gtr:fundingOrg><gtr:id>F22B239A-797E-443B-BCA8-F09643F64CD5</gtr:id><gtr:outcomeId>5F5484B5C660</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>116953</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU-Network of Excellence-FP6</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>C332D1A5-8E37-4812-9653-EA5CFE86AB55</gtr:id><gtr:outcomeId>454B9253C2E0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25352</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dana Foundation Research Grant-2007</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Dana Foundation</gtr:fundingOrg><gtr:id>E9011DC4-2FAF-4E6C-BAB4-AAFEEBEC0686</gtr:id><gtr:outcomeId>4CAE81D3FFA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1550000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Research Council ERC 2011 AdG</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>294682 - TB-PATH</gtr:fundingRef><gtr:id>AC461061-3577-4610-890E-BE5DBA188188</gtr:id><gtr:outcomeId>sbsLEa8zayP</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>235050</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Training Fellowship (2009)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CEC56433-9D0D-4122-9144-674C0F3C0F94</gtr:id><gtr:outcomeId>3D4104AE2530</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (M. tuberculosis), is a major cause of morbidity and mortality worldwide and efforts to control TB are hampered by difficulties with diagnosis, prevention and treatment 1,2. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease, but current tests cannot identify which individuals will develop disease 3. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines 4,5. We identified a whole blood 393 transcript signature for active TB in intermediate and high burden settings, correlating with radiological extent of disease and reverting to that of healthy controls following treatment. A subset of latent TB patients had signatures similar to those in active TB patients. We also identified a specific 86-transcript signature that discriminated active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-? and Type I IFNa? signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis, suggest that this TB signature reflects both changes in cellular composition and altered gene expression. Although an IFN signature was also observed in whole blood of patients with Systemic Lupus Erythematosus (SLE), their complete modular signature differed from TB with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto under-appreciated role of Type I IFNa? signalling in TB pathogenesis, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.</gtr:description><gtr:grantRef>MC_U117565642</gtr:grantRef><gtr:id>FC3A26E0-665A-46AA-BA28-110CA2690460</gtr:id><gtr:impact>Interest and funding from company Institut Merieux</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>PJkbMpWPF9X</gtr:outcomeId><gtr:patentId>WO2011066008</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Blood transcriptional signature of active versus latent tuberculosis infection</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Transcriptional profiling of blood distinguishes patients with active tuberculsosis disease from those with latent tuberculosis (asymptomatic) and healthy controls</gtr:description><gtr:grantRef>MC_U117565642</gtr:grantRef><gtr:id>7A8468C7-84D7-4D23-913C-788BCDA26337</gtr:id><gtr:impact>This discovery has potential for diagnosis tuberculosis during active disease and in latent patients who may be asymptomatic but will reactivate disease. The transcriptional profile is diminished upon drug treatment. This transcriptional profile may be effective in monitoring and directing treatment of patients.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>665236ED8E6</gtr:outcomeId><gtr:patentId>WO2009158521</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>BLOOD TRANSCRIPTIONAL SIGNATURE OF MYCOBACTERIUM TUBERCULOSIS INFECTION</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D841194-F67E-4FED-8520-45AF9D998A21</gtr:id><gtr:title>Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e2411f078e9f433fac4588f7355e8a6"><gtr:id>5e2411f078e9f433fac4588f7355e8a6</gtr:id><gtr:otherNames>Pitt JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d84b74cd8629.88389181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE84BE06-E5A8-4A3F-AABF-2B2734FCF77B</gtr:id><gtr:title>Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68cef74f1c843669afb9864d23c5dad2"><gtr:id>68cef74f1c843669afb9864d23c5dad2</gtr:id><gtr:otherNames>Veldhoen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>1466C450DF0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69A57EB4-9383-4F48-8BA5-480963A4272B</gtr:id><gtr:title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24937c52f3e003821cef5ec97ad336a"><gtr:id>b24937c52f3e003821cef5ec97ad336a</gtr:id><gtr:otherNames>Berry MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>54604eb7c57ef9.83705382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2F284B2-606C-461E-B45A-A1117443F928</gtr:id><gtr:title>The regulation of IL-10 production by immune cells.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff415992ddaaba6ac42c64043f56a1c5"><gtr:id>ff415992ddaaba6ac42c64043f56a1c5</gtr:id><gtr:otherNames>Saraiva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>54604eb77e2773.49115242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>356FF4C8-8497-48F1-8F66-030FE300BA62</gtr:id><gtr:title>Regula'ten' the gut.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8373d5e7b1a64cad8bbead0137a7bfad"><gtr:id>8373d5e7b1a64cad8bbead0137a7bfad</gtr:id><gtr:otherNames>Vieira P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>09E2B73ABB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECA6841E-C5FF-4FF0-8016-AD86761FBD8D</gtr:id><gtr:title>Remembering Ralph Steinman.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f92b85ed278c9d29cfe8627389c64c9b"><gtr:id>f92b85ed278c9d29cfe8627389c64c9b</gtr:id><gtr:otherNames>Banchereau J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_16120_20_22216461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A07B5AE-6344-480B-9217-5D5675AED51B</gtr:id><gtr:title>CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e594b4d961b4254d8bbc93b16be0df6"><gtr:id>7e594b4d961b4254d8bbc93b16be0df6</gtr:id><gtr:otherNames>Barthlott T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>DE56C89E65B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00900A6F-40EC-48F6-A187-798AD42F4E7F</gtr:id><gtr:title>THE IDENTIFICATION OF DISTINCT GENE EXPRESSION PROFILES IN LATENT AND ACTIVE TUBERCULOSIS</gtr:title><gtr:parentPublicationTitle>THORAX</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a5df7d3e8e5cac5dacb3f3aac628e0e"><gtr:id>4a5df7d3e8e5cac5dacb3f3aac628e0e</gtr:id><gtr:otherNames>Berry M. P. R.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>6812250961C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EF3FE90-E1BD-4674-A29E-8427A58BED3C</gtr:id><gtr:title>Mycobacterium tuberculosis and its ability to resist immunity.</gtr:title><gtr:parentPublicationTitle>Novartis Foundation symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f62a14bcada96d118c76808c0e0157"><gtr:id>69f62a14bcada96d118c76808c0e0157</gtr:id><gtr:otherNames>Young D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1528-2511</gtr:issn><gtr:outcomeId>D1CA256695C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F31F345-C8D1-47A1-A555-33CC1E92A563</gtr:id><gtr:title>Identification of the key differential transcriptional responses of human whole blood following TLR2 or TLR4 ligation in-vitro.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f524967bbd1de91bc2d075c2e1745cf1"><gtr:id>f524967bbd1de91bc2d075c2e1745cf1</gtr:id><gtr:otherNames>Blankley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546049cbf35965.62820667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>492215F0-8F5B-44E1-95AA-CBEA89F797CC</gtr:id><gtr:title>Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff415992ddaaba6ac42c64043f56a1c5"><gtr:id>ff415992ddaaba6ac42c64043f56a1c5</gtr:id><gtr:otherNames>Saraiva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>54604eb6e3cfe3.73229926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8697F27-FD3F-48FC-830B-9CDE820A6CAF</gtr:id><gtr:title>IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c51ab8d47a8d73f33012f7b60f02ebc8"><gtr:id>c51ab8d47a8d73f33012f7b60f02ebc8</gtr:id><gtr:otherNames>Freitas do Ros?rio AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16120_20_22205023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>846A9B9E-22A7-41F7-89B7-00F7D33A9611</gtr:id><gtr:title>Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e0a5d2a9fb4b2a7f0732cbdb5ea681d"><gtr:id>1e0a5d2a9fb4b2a7f0732cbdb5ea681d</gtr:id><gtr:otherNames>Hawrylowicz CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>6288DCB7935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5632822-0D06-4C66-92A2-ECB36A14F81E</gtr:id><gtr:title>Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9590b91c583a8a7a2f84c0e7c103bfc4"><gtr:id>9590b91c583a8a7a2f84c0e7c103bfc4</gtr:id><gtr:otherNames>Redford PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>54604eb7a4acb4.56178467</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79A9F5CA-CF91-4D8D-9F79-1A280DE5ECDB</gtr:id><gtr:title>Integrated T-cell receptor and costimulatory signals determine TGF-?-dependent differentiation and maintenance of Foxp3+ regulatory T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/067285678021f2985bb69405588078b7"><gtr:id>067285678021f2985bb69405588078b7</gtr:id><gtr:otherNames>Gabry?ov? L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_16120_20_21469110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29916322-70C3-427E-AFEA-B28A3E2D23BA</gtr:id><gtr:title>Systems approach to understand the immune response in tuberculosis: an iterative process between mouse models and human disease.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor symposia on quantitative biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-7451</gtr:issn><gtr:outcomeId>pm_16120_20_24100583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C76B212-D602-4587-B47E-8ADC3A132497</gtr:id><gtr:title>The regulation of IL-10 expression.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/067285678021f2985bb69405588078b7"><gtr:id>067285678021f2985bb69405588078b7</gtr:id><gtr:otherNames>Gabry?ov? L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>546049cc258e46.73023351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>575E0ADE-5EC1-4952-A5C9-1D5BDBB25CC3</gtr:id><gtr:title>Brigitte Askonas (1923-2013).</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_16120_20_23389536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B0EA4D-5A5B-4A39-94BF-715C025BA732</gtr:id><gtr:title>ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01b64555503284b8ffcc59220c1303b6"><gtr:id>01b64555503284b8ffcc59220c1303b6</gtr:id><gtr:otherNames>Papoutsopoulou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>C3FA0B4ABCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6E2145C-C500-4BD5-BA28-158950B38EA0</gtr:id><gtr:title>Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36dd7b04566862cd34ba73b866222d4d"><gtr:id>36dd7b04566862cd34ba73b866222d4d</gtr:id><gtr:otherNames>Rowland CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>B7909FD1234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAB03C36-F71E-4F59-A717-83C6600F5A92</gtr:id><gtr:title>Tripartite-motif proteins and innate immune regulation.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_16120_20_21131187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C81B38EA-6FB8-4213-840B-7FB734A8F452</gtr:id><gtr:title>Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9590b91c583a8a7a2f84c0e7c103bfc4"><gtr:id>9590b91c583a8a7a2f84c0e7c103bfc4</gtr:id><gtr:otherNames>Redford PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_16120_20_23935205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07EEAE71-2750-4ACB-AB72-332DA50F1CDA</gtr:id><gtr:title>The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f524967bbd1de91bc2d075c2e1745cf1"><gtr:id>f524967bbd1de91bc2d075c2e1745cf1</gtr:id><gtr:otherNames>Blankley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c3e7eed97744.39057001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0012EF3-E3CB-41E7-B0C9-A50246F3DD73</gtr:id><gtr:title>Systems approaches to studying the immune response in tuberculosis.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24937c52f3e003821cef5ec97ad336a"><gtr:id>b24937c52f3e003821cef5ec97ad336a</gtr:id><gtr:otherNames>Berry MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_16120_20_24021227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>884063D9-3EA6-4564-9E8E-63C05F550D96</gtr:id><gtr:title>The role of 1a,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60adf3e827f59f9e759e71e6b8e242a6"><gtr:id>60adf3e827f59f9e759e71e6b8e242a6</gtr:id><gtr:otherNames>Urry Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_16120_20_22903229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E997B6FC-AF16-4BC8-A369-6B1197A9734E</gtr:id><gtr:title>Contribution of cytokines to pathology and protection in virus infection.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/863ba9a68a78985690bfadc5f104bf49"><gtr:id>863ba9a68a78985690bfadc5f104bf49</gtr:id><gtr:otherNames>Wack A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>pm_16120_20_22440716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC30FCDC-1F99-442A-8DD7-C2B5A7EB51F1</gtr:id><gtr:title>From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f92b85ed278c9d29cfe8627389c64c9b"><gtr:id>f92b85ed278c9d29cfe8627389c64c9b</gtr:id><gtr:otherNames>Banchereau J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_16120_20_22990890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E05D7C9B-9E2B-41E9-92CC-4D738EFE1EFC</gtr:id><gtr:title>From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>54604eb7369898.72520078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A086BF-AA29-4337-A938-497052A26455</gtr:id><gtr:title>Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64669c469bb85c14af6967c259e5623b"><gtr:id>64669c469bb85c14af6967c259e5623b</gtr:id><gtr:otherNames>Sriskantharajah S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>546049cb78b1c4.69821248</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE148902-17FE-4582-A216-E82FF721E97F</gtr:id><gtr:title>Highlights of 10 years of immunology in Nature Reviews Immunology.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd4325b6eb2d08ffc96ac2aba4e1e23f"><gtr:id>cd4325b6eb2d08ffc96ac2aba4e1e23f</gtr:id><gtr:otherNames>Medzhitov R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_16120_20_21941295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9C5FAF2-0E19-45E4-B6A1-E7725B0DF986</gtr:id><gtr:title>Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80bc4e810eb285617d596b9cf41df306"><gtr:id>80bc4e810eb285617d596b9cf41df306</gtr:id><gtr:otherNames>Boonstra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5A2BD742E8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B892415D-F88A-4270-B38A-6CA7CBE2E0C8</gtr:id><gtr:title>Immunology. Immunity benefits from a little suppression.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a54e4ccd802f58d67f9eef3a0a2961"><gtr:id>e5a54e4ccd802f58d67f9eef3a0a2961</gtr:id><gtr:otherNames>Kassiotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>E34BB31B1E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>477C591F-BC82-47AE-BE46-2877C63A68EE</gtr:id><gtr:title>Differentiation of human T(H)-17 cells does require TGF-beta!</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>07236914067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B64A7942-A827-48FA-95F8-61956994AAB2</gtr:id><gtr:title>A 380-gene meta-signature of active tuberculosis compared with healthy controls.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f524967bbd1de91bc2d075c2e1745cf1"><gtr:id>f524967bbd1de91bc2d075c2e1745cf1</gtr:id><gtr:otherNames>Blankley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58c3e902b76063.06458174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3B995F2-2E2E-4F81-85D7-7C8B4692F37E</gtr:id><gtr:title>Identification of a macrophage-specific chromatin signature in the IL-10 locus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff415992ddaaba6ac42c64043f56a1c5"><gtr:id>ff415992ddaaba6ac42c64043f56a1c5</gtr:id><gtr:otherNames>Saraiva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>E42A7805100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56D5BE8E-E18D-4FD9-B86A-92CEB4505B64</gtr:id><gtr:title>Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b14faa6c82d6745215fcf68ae6f4221"><gtr:id>8b14faa6c82d6745215fcf68ae6f4221</gtr:id><gtr:otherNames>Haque A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>DBE8E3578B5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D73630B7-15AD-4E1A-A44A-2FE1C34EF37D</gtr:id><gtr:title>Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a816de6a63c6a3a5f15aba6f35974a35"><gtr:id>a816de6a63c6a3a5f15aba6f35974a35</gtr:id><gtr:otherNames>Rajsbaum R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>D21D283242B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EC0982C-ED7E-4603-B6D3-E64C45EF06DB</gtr:id><gtr:title>The Blood Transcriptome of Experimental Melioidosis Reflects Disease Severity and Shows Considerable Similarity with the Human Disease.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06cd32e6a242c0c9bbdd127f2c6a5cb2"><gtr:id>06cd32e6a242c0c9bbdd127f2c6a5cb2</gtr:id><gtr:otherNames>Conejero L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56d84b752a8498.35982141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>903A1E31-1B4C-43D8-808D-76255A38414F</gtr:id><gtr:title>Breakpoints in immunoregulation required for Th1 cells to induce diabetes.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d910179d9cf9c0464fb74140ede5a47f"><gtr:id>d910179d9cf9c0464fb74140ede5a47f</gtr:id><gtr:otherNames>Neighbors M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>29B20F9A007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8D75B69-5C7A-4CDE-B6D3-E13EE6886CCE</gtr:id><gtr:title>Neutrophils in tuberculosis: friend or foe?</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fffeea0403dfb5c4fb207ad1992bd697"><gtr:id>fffeea0403dfb5c4fb207ad1992bd697</gtr:id><gtr:otherNames>Lowe DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_16120_20_22094048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>541C5A71-46C6-4F39-99DB-8AAB14FF5F6E</gtr:id><gtr:title>T(H)1 cells control themselves by producing interleukin-10.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>72BB53E3DB8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41B0A3B-284C-4AD2-8DA2-9249E5ABB9DF</gtr:id><gtr:title>Blockade of IL-10 signaling during bacillus Calmette-Gu&amp;eacute;rin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-? and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e2411f078e9f433fac4588f7355e8a6"><gtr:id>5e2411f078e9f433fac4588f7355e8a6</gtr:id><gtr:otherNames>Pitt JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16120_20_22972927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>128004D8-7578-44A4-AF3F-6788B9609B2C</gtr:id><gtr:title>T Cell-Derived IL-10 Impairs Host Resistance toInfection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5590e21c72febcdf078f2217a4901b17"><gtr:id>5590e21c72febcdf078f2217a4901b17</gtr:id><gtr:otherNames>Moreira-Teixeira L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a31d919403426.58448548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AF08364-4297-4331-8F00-0405AD3B5487</gtr:id><gtr:title>Signatures of malaria-associated pathology revealed by high-resolution whole-blood transcriptomics in a rodent model of malaria.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21bbb72e73fb429ca385ad649f22bdd2"><gtr:id>21bbb72e73fb429ca385ad649f22bdd2</gtr:id><gtr:otherNames>Lin JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c3e746017455.95861191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50C73DA1-CDCA-4CC4-B173-A80459D5CDEB</gtr:id><gtr:title>Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c177438eb79003ac9ce2f1bf60846b31"><gtr:id>c177438eb79003ac9ce2f1bf60846b31</gtr:id><gtr:otherNames>Tattermusch S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16120_20_22291590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6846538B-0999-4C26-B28E-7A887EDA38D2</gtr:id><gtr:title>Driving change in tuberculosis research: an interview with Anne O'Garra.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>pm_16120_20_23268534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C30A0B39-4745-4C30-A128-E83FF0E41F63</gtr:id><gtr:title>Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[F]fluoro-D-glucose positron emission and computed tomography.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/848b1182bacc3744b0524d03a96345a5"><gtr:id>848b1182bacc3744b0524d03a96345a5</gtr:id><gtr:otherNames>Esmail H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>58c3e85b1be0b5.46055889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79EDDBE7-C060-4B25-BD5A-46C061C13D25</gtr:id><gtr:title>Preface. The science of infectious diseases.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b118d5dd24254584b1762c9f465f0e"><gtr:id>92b118d5dd24254584b1762c9f465f0e</gtr:id><gtr:otherNames>Dye C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>546049cbcdd732.69682950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BDEB5C8-2C36-4B60-9693-77C9E6E3F5F5</gtr:id><gtr:title>NF-?B1 inhibits TLR-induced IFN-? production in macrophages through TPL-2-dependent ERK activation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70bc412b1ff07d0fd9db666ee9f98b16"><gtr:id>70bc412b1ff07d0fd9db666ee9f98b16</gtr:id><gtr:otherNames>Yang HT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16120_20_21217011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB7A40BE-2D18-4F9D-941E-CCDD945FA41A</gtr:id><gtr:title>Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d29de4809bfdda46518e1a7a781512"><gtr:id>26d29de4809bfdda46518e1a7a781512</gtr:id><gtr:otherNames>Marais S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>58c3e77d909174.35874420</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB5FCAA5-90D2-48B3-8628-865B37BEC115</gtr:id><gtr:title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-? for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>546049cc4f4b94.67833211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E001628-B77F-4D5C-AA7C-7581806095D0</gtr:id><gtr:title>Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26f74e3b75b0db80a96ce4bb0ae0ae74"><gtr:id>26f74e3b75b0db80a96ce4bb0ae0ae74</gtr:id><gtr:otherNames>Sponaas AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>E573B32CE69</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7C8C038-1D0A-4E4D-8D49-FC2A9992A58E</gtr:id><gtr:title>Strategies for use of IL-10 or its antagonists in human disease.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>8127F2D8AF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44ADAE18-A4B4-4DE6-8EF6-9660079E072F</gtr:id><gtr:title>Differential post-transcriptional regulation of IL-10 by TLR2 and TLR4-activated macrophages.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34a2cf8e55d0e118db20a868033c73b0"><gtr:id>34a2cf8e55d0e118db20a868033c73b0</gtr:id><gtr:otherNames>Teixeira-Coelho M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>546049cb4fbcd8.43986325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCFFEDCC-587F-49FA-858A-BA3E413CADBE</gtr:id><gtr:title>The role of IL-10 in immune regulation during M. tuberculosis infection.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9590b91c583a8a7a2f84c0e7c103bfc4"><gtr:id>9590b91c583a8a7a2f84c0e7c103bfc4</gtr:id><gtr:otherNames>Redford PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>pm_16120_20_21451501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD70D336-1963-4CA5-9029-D4FC9F9D3092</gtr:id><gtr:title>Editorial overview.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_16120_20_22867964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3189B9A-746F-470B-AE1D-51AA8F4ECC90</gtr:id><gtr:title>GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87fd87192d6b6f3e2f9d6a57e49ec498"><gtr:id>87fd87192d6b6f3e2f9d6a57e49ec498</gtr:id><gtr:otherNames>Shoemaker J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>FFA956F989C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B78FD3B1-0B09-483A-B57E-B63433F797A2</gtr:id><gtr:title>The human immune response to tuberculosis and its treatment: a view from the blood.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/448c3e6a3b507d4f3031c409ae4f2f09"><gtr:id>448c3e6a3b507d4f3031c409ae4f2f09</gtr:id><gtr:otherNames>Cliff JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>56d84b7501c974.88476591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31C33C56-A099-4B0B-9B0B-C89531D4FEB2</gtr:id><gtr:title>IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/257f19e93575ae4a797aea2abe7ee46f"><gtr:id>257f19e93575ae4a797aea2abe7ee46f</gtr:id><gtr:otherNames>Loebbermann J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16120_20_22393401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC0FB413-C5C4-41D6-BE16-E9B2E66C61D0</gtr:id><gtr:title>Quantitative events determine the differentiation and function of helper T cells.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_16120_20_21423225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0854B1A3-3DA6-476A-AB0E-31A97882E8CE</gtr:id><gtr:title>Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-? Signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5590e21c72febcdf078f2217a4901b17"><gtr:id>5590e21c72febcdf078f2217a4901b17</gtr:id><gtr:otherNames>Moreira-Teixeira L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58c3e7aeb3b827.70085392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F7504A7-7FD3-4A7D-A6A0-1CA8F62FF357</gtr:id><gtr:title>TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c8fa26f42517725aca7797211e2a242"><gtr:id>8c8fa26f42517725aca7797211e2a242</gtr:id><gtr:otherNames>Rousseau S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>CAA8D8A0B12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54586F1-747D-4DE2-9060-72CF1357BFED</gtr:id><gtr:title>Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97d116e9d5bce159f1cde867157a7d02"><gtr:id>97d116e9d5bce159f1cde867157a7d02</gtr:id><gtr:otherNames>Xystrakis E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>0D4592DC96E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB710FA1-96FD-4D5A-9A28-20DE409942A2</gtr:id><gtr:title>Type I interferons in infectious disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c8b047c051be00c3575d1c495142dfb"><gtr:id>3c8b047c051be00c3575d1c495142dfb</gtr:id><gtr:otherNames>McNab F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>56d84b758d4381.33888439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F0E8D4B-96F6-44F4-A2EC-B4C7B04EF5DE</gtr:id><gtr:title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c412c1efe9a2472d77a8453018de3f"><gtr:id>a0c412c1efe9a2472d77a8453018de3f</gtr:id><gtr:otherNames>Bloom CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16120_20_23940611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63877626-C1FC-4785-8EA8-FEA7F72EC02D</gtr:id><gtr:title>Establishing the follicular helper identity.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a54e4ccd802f58d67f9eef3a0a2961"><gtr:id>e5a54e4ccd802f58d67f9eef3a0a2961</gtr:id><gtr:otherNames>Kassiotis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>54604eb759c650.01985264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D4F358-F560-4D58-A371-E4AF22770C0C</gtr:id><gtr:title>TPL-2 negatively regulates interferon-beta production in macrophages and myeloid dendritic cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db0cfc85ea46e706ad1913522208ff7"><gtr:id>9db0cfc85ea46e706ad1913522208ff7</gtr:id><gtr:otherNames>Kaiser F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>54604eb7149e35.81689408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB695EEB-AA20-4BFE-B359-00179F813893</gtr:id><gtr:title>HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6930ae71879c40ce14c54ab812f00c23"><gtr:id>6930ae71879c40ce14c54ab812f00c23</gtr:id><gtr:otherNames>Lai RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d84b7561abf4.34455177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D038F3-C71E-477A-ACF7-1E15143815F3</gtr:id><gtr:title>Cytokines in tuberculosis</gtr:title><gtr:parentPublicationTitle>Handbook of tuberculosis. Immunology and Cell Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7c7ac0c2454e52055586cff84615e39"><gtr:id>f7c7ac0c2454e52055586cff84615e39</gtr:id><gtr:otherNames>Anne O'Garra;Warwick J. Britton</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>3A3380D7537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55B5CA23-6F0E-47FF-8F29-A8FF91F34B76</gtr:id><gtr:title>Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_16120_20_21509782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB96D36-B7D0-4A14-AFA8-B61A52BE45AC</gtr:id><gtr:title>Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe9b042046523eb6ce0dea7145975a76"><gtr:id>fe9b042046523eb6ce0dea7145975a76</gtr:id><gtr:otherNames>Howes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d6b9a7d4d99.99702506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F41575EB-0B6D-4A1E-A517-582B1CE3CDA1</gtr:id><gtr:title>TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a567e445f45cd9579c85c397f97b850e"><gtr:id>a567e445f45cd9579c85c397f97b850e</gtr:id><gtr:otherNames>McNab FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_16120_20_23842752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13FC9A1E-3EE9-43FD-A48E-A53C230B88E5</gtr:id><gtr:title>Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_16120_20_22213806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF10E2D3-318E-49BA-9F9C-74139341CEAE</gtr:id><gtr:title>The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f524967bbd1de91bc2d075c2e1745cf1"><gtr:id>f524967bbd1de91bc2d075c2e1745cf1</gtr:id><gtr:otherNames>Blankley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>546049cba17f50.81020904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>340E0C9B-55A9-4CED-AAEB-0BFE395046F9</gtr:id><gtr:title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c412c1efe9a2472d77a8453018de3f"><gtr:id>a0c412c1efe9a2472d77a8453018de3f</gtr:id><gtr:otherNames>Bloom CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16120_20_23056259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03BB07E7-35AA-4067-9A92-A3866B14C03C</gtr:id><gtr:title>Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daaae0af1fef7a8733dd7167b19ccecb"><gtr:id>daaae0af1fef7a8733dd7167b19ccecb</gtr:id><gtr:otherNames>Okada T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>7B2C37D5AA6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA07E51B-5C76-4809-9519-3B33CBA9E027</gtr:id><gtr:title>The immune response in tuberculosis.</gtr:title><gtr:parentPublicationTitle>Annual review of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eed50353f8788bcf607157c4b73f9aad"><gtr:id>eed50353f8788bcf607157c4b73f9aad</gtr:id><gtr:otherNames>O'Garra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0732-0582</gtr:issn><gtr:outcomeId>pm_16120_20_23516984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECA01A2-8A0A-4D38-A5B3-AB50AAB8E39E</gtr:id><gtr:title>Vaccination against tuberculosis: how can we better BCG?</gtr:title><gtr:parentPublicationTitle>Microbial pathogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e2411f078e9f433fac4588f7355e8a6"><gtr:id>5e2411f078e9f433fac4588f7355e8a6</gtr:id><gtr:otherNames>Pitt JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0882-4010</gtr:issn><gtr:outcomeId>pm_16120_20_23257069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F5CB3A0-CAAD-4C95-B57F-89EDA2189A86</gtr:id><gtr:title>Type I interferon dependence of plasmacytoid dendritic cell activation and migration.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ffbd163d11813896ce250148dc545bd"><gtr:id>6ffbd163d11813896ce250148dc545bd</gtr:id><gtr:otherNames>Asselin-Paturel C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>7AF41A03EF0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117565642</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>